Title : Trandolapril: a newer angiotensin-converting enzyme inhibitor.

Pub. Date : 2003 Mar

PMID : 12852701






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Trandolapril: a newer angiotensin-converting enzyme inhibitor. trandolapril angiotensin I converting enzyme Homo sapiens
2 BACKGROUND: Trandolapril is a newer angiotensin-converting enzyme (ACE) inhibitor that is approved by the US Food and Drug Administration for the treatment of hypertension and for use in stable patients who have evidence of left ventricular (LV) systolic dysfunction or symptoms of chronic heart failure within the first 2 days after an acute myocardial infarction (AMI). trandolapril angiotensin I converting enzyme Homo sapiens
3 BACKGROUND: Trandolapril is a newer angiotensin-converting enzyme (ACE) inhibitor that is approved by the US Food and Drug Administration for the treatment of hypertension and for use in stable patients who have evidence of left ventricular (LV) systolic dysfunction or symptoms of chronic heart failure within the first 2 days after an acute myocardial infarction (AMI). trandolapril angiotensin I converting enzyme Homo sapiens
4 RESULTS: Trandolapril has a sufficient duration of inhibition of plasma ACE activity to allow once-daily dosing. trandolapril angiotensin I converting enzyme Homo sapiens